About 120 million unintended pregnancies occurred each year between 2015 and 2019 worldwide (https://www.guttmacher.org/fact-sheet/induced-abortion-worldwide). While there are oral contraceptives for women, the development of oral contraceptives for men has not been successful. Now, a team from Osaka University has used protein sequence data analysis and genome editing technology to find that SPATA33 plays an important role in sperm motility regulation, which will help develop male contraceptives.
It was previously known that calcineurin, a calcium-dependent phosphatase, plays an important role in regulating sperm motility. Calcineurin is considered a good target for male contraceptives because administration of calcineurin inhibitors to male mice causes reversible infertility in a short period of time.
“However, since calcineurin also has an important function in immunity, there is a problem that if calcineurin in immune cells is inhibited, immune function will also be suppressed. Therefore, our goal was to elucidate the mechanism that regulates the function of calcineurin specifically in the sperm,” says corresponding author Masahito Ikawa.
The research group focused on the PxIxIT motif that can be found in many proteins that bind to calcineurin. From the approximately 20,000 mouse proteins, eight proteins were found which contain the PxIxIT motif and are expressed predominantly in the testis (Figure 1).
“Genome editing technology was then used to generate knockout mice for three of these proteins that had not been previously analyzed. As a result, SPATA33 knockout mice showed impaired sperm motility and fertility defects, similar to calcineurin knockout mice,” explains lead author Haruhiko Miyata. “Further analysis revealed that SPATA33 regulates the localization of calcineurin. When SPATA33 is knocked out, calcineurin cannot localize to the midpiece of the sperm tail and the midpiece cannot bend, leading to impaired sperm motility (Figure 2).”
Targeting SPATA33 may lead to the development of male contraceptives that specifically inhibit calcineurin function in sperm. In addition, the mechanism by which SPATA33 controls sperm motility has been clarified in this study, adding a new perspective to the investigation and diagnosis of the cause of male infertility.
“We would like to further clarify the regulation mechanism of sperm motility by calcineurin in its entirety. We expect our findings will lead to the development of fast-acting, reversible male contraceptives and the investigation of the cause of male infertility due to decreased sperm motility,” says Haruhiko Miyata.
###
The article, “SPATA33 localizes calcineurin to the mitochondria and regulates sperm motility in mice,” was published in Proceedings of the National Academy of Sciences at DOI: https://doi.org/10.1073/pnas.2106673118
About Osaka University
Osaka University was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world, being named Japan's most innovative university in 2015 (Reuters 2015 Top 100) and one of the most innovative institutions in the world in 2017 (Innovative Universities and the Nature Index Innovation 2017). Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
Journal
Proceedings of the National Academy of Sciences
Method of Research
Experimental study
Subject of Research
Animals
Article Title
SPATA33 localizes calcineurin to the mitochondria and regulates sperm motility in mice
Article Publication Date
22-Aug-2021